Daiichi Sankyo predecessor agreed to plead guilty to vitamin B5 price fixing

Summary

On September 9, 1999, Daiichi Pharmaceutical Co., Ltd., a predecessor that later combined with Sankyo to form Daiichi Sankyo, agreed to plead guilty and pay a $25 million criminal fine for fixing prices and allocating sales of vitamin B5. DOJ said the collusion ran from early 1991 into February 1999. The announcement states that sentencing and court acceptance of the plea agreement were still required. Primary source: https://www.justice.gov/archive/opa/pr/1999/September/404at.htm ; corporate history: https://www.daiichisankyo.com/about_us/mission-strength/history/